Ranbaxy launches acne drug in US
REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc (DND.TO), said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)
- Tweet this
- Share this
- Digg this
Trending On Reuters
Investors in India's markets are betting that Finance Minister Arun Jaitley will persuade a more hawkish central bank to reduce benchmark interest rates as early as next week. Full Article